Search

Rob is a Chief Technology Officer based in Manchester, with over 20 years’ experience leading technology, software development and digital transformation.

• Trustee
• Written

Formal notice of the forthcoming Annual General Meeting in July 2026.

• News

We employ a number of full and part-time staff. Our office is in Buckingham.

Martin's son was diagnosed with Stargardt’s at a young age which has led Martin to take a close interest in the progress of research into Retinal disease.

• Trustee
• Written

Roger has retinitis pigmentosa, as do his son, mother and grandfather. He was officially diagnosed aged 16.

• Trustee
• Written

Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.

• Trustee
• Written

Prof John Marshall is the Frost Professor of Ophthalmology at the Institute of Ophthalmology at University College London.

• Trustee
• Written

Simon spent 40 years as a consultant ophthalmic surgeon at the North Hampshire Hospital in Basingstoke.

• Trustee
• Written

Colin McArthur re-joined the board in 2024 after serving as a trustee between January 2008 and September 2019.

• Trustee
• Written

Ashley is currently the Vice President & Chief Financial Officer, International for Vertex Pharmaceuticals.

• Trustee
• Written